UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053278
Receipt number R000060810
Scientific Title Retrospective observational study comparing comparing post-COVID conditions incidence in COVID-19 patients between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan (3-month follow-up)
Date of disclosure of the study information 2024/01/09
Last modified on 2024/01/10 18:39:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retrospective observational study comparing comparing post-COVID conditions incidence in COVID-19 patients between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan (3-month follow-up)

Acronym

Retrospective observational study comparing comparing post-COVID conditions incidence in COVID-19 patients between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan (3-month follow-up)

Scientific Title

Retrospective observational study comparing comparing post-COVID conditions incidence in COVID-19 patients between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan (3-month follow-up)

Scientific Title:Acronym

Retrospective observational study comparing comparing post-COVID conditions incidence in COVID-19 patients between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan (3-month follow-up)

Region

Japan


Condition

Condition

COVID-19

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the efficacy of ensitrelvir in reducing post-COVID conditions incidence in COVID-19 patients with molnupiravir, nirmatrelvir or no antiviral as a control using the insurance claims database

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Post-COVID conditions incidence from 2 to 3 months after the month of diagnosis of COVID-19

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients whose index month (IM) of COVID-19 diagnosis is during the enrollment period (2022/11 to 2023/05).
2. Patients with observable period of 6 months before IM
3. Patients with observable period up to 3 months after IM

Key exclusion criteria

1. Patients under 18 years of age at the time of IM
2. Patients with dispending days of multiple anti-SARS-CoV-2 drugs in IM
3. Patients with a COVID-19 diagnosis within 3 months prior to IM
4. Patients who have been diagnosed with the same event as the post-COVID condition within 6 months before IM
5. Patients at risk of severe COVID-19

Target sample size

300000


Research contact person

Name of lead principal investigator

1st name Yoshitake
Middle name
Last name Kitanishi

Organization

Shionogi & Co., Ltd.

Division name

Data Science Department

Zip code

541-0047

Address

4F, Midosuji MTR Building, 6-3, Awajimachi 3-chome, Chuo-ku, Osaka-shi, Osaka

TEL

06-6202-2161

Email

yoshitake.kitanishi@shionogi.co.jp


Public contact

Name of contact person

1st name Takuji
Middle name
Last name Komeda

Organization

Shionogi & Co., Ltd.

Division name

Data Science Department

Zip code

541-0047

Address

4F, Midosuji MTR Building, 6-3, Awajimachi 3-chome, Chuo-ku, Osaka-shi, Osaka

TEL

070-7812-6558

Homepage URL


Email

takuji.komeda@shionogi.co.jp


Sponsor or person

Institute

Shionogi & Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Shionogi & Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

NA

Address

NA

Tel

0000000000

Email

XXXX@XXXX


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 01 Month 05 Day

Date of IRB


Anticipated trial start date

2024 Year 01 Month 05 Day

Last follow-up date

2025 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2024 Year 01 Month 05 Day

Last modified on

2024 Year 01 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060810


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name